Prescribing of nonsteroidal anti-inflammatory drugs in general practice: Determinants and consequences

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 2, 1997, Pages 293-298

  Hawkey, C J ^a   Cullen, D J E ^a,b   Greenwood, D C ^c   Wilson, J V ^d   Logan, R F A ^a,c  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d Nottingham Health Authority   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BLEEDING; GASTROINTESTINAL SYMPTOM; HUMAN; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0030939465     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.150326000.x     Document Type: Article

References (30)

1. Hawkey CJ. Non steroidal anti inflammatory drugs & peptic ulcers; facts and figures multiply but do they add up? Br Med J 1990; 300: 278-84.
2. Griffin MR, Piper JM, Daugherty JR, et al. Non steroidal anti inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991; 114: 257-63.
3. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991; 115: 787-96.
4. Garcia Rodriguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non steroidal anti inflammatory drugs. Lancet 1994; 343: 769-74.
5. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non steroidal anti inflammatory drugs. Lancet 1994; 343: 1075-8.
6. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non steroidal anti inflammatory drugs - a randomised double blind placebo controlled study. Ann Intern Med 1995; 123: 241-9.
7. Health Economics Consortium. 'Seven part deprivation index ' University of York, 1989.
8. Roberts SJ, Harris CM. Age, sex and temporary resident originated prescribing units (ASTRO-PUs). Br Med J 1993; 307: 485-8.
9. Harris CM. Better feedback for prescribing for general practitioners. Br Med J 1994; 309: 356.
10. Bogle SM, Harris CM. Measuring prescribing-the shortcomings of the item. Br Med J 1994; 308: 637-40.
11. Epidemiological graphics estimation and testing (EGRET). Seattle Statistics and Epidemiology Research Corporation and Cytel Software Corporation. 1985-1991.
12. Statistical Bulletin August 1993. Department of Health, Health Publication Unit, Lancashire.
13. OPCS Mortality Statistics, England and Wales; Cause. No. 201993. London: HMSO, 1995.
14. Sartor F, Ealckiers D. Estimate of disease prevalence using drug consumption data. Am J Epidemiol 1995; 141: 782-7.
15. Hallas J, Lauritsen J, Villadsen HD, Gram LF. Non steroidal anti inflammatory drugs and upper gastrointestinal bleeding, identifying high risk groups by excess risk estimates. Scand J Gastroenterol 1995; 30: 438-14.
16. Pharoah PDP, Melzer D. Variation in prescribing of hypnotics, anxiolytics and antidepressants between 61 general practices. Brit J Gen Pract 1995; 45: 595-9.
17. Hawkey CJ, Cullen DJ, Pearson G, et al. Pharmacoepidemiology of non steroidal anti inflammatory drug use in Nottingham general practices. Health Trends (submitted).
18. Jarman B. Identification of underprivileged areas. Br Med J 1983; 286: 1705-9.
19. Townsend H, Philimore P, Beattie A. Health and Deprivation: Inequality and the North. London: Routledge, 1988.
20. Morris R, Carstairs V. Which deprivation index? A comparison of selected deprivation indices. J Public Health Med 1991; 13: 318-26.
21. Pringle M, Morton Jones A. Using unemployment rates to predict prescribing trends in England. Brit J Gen Pract 1994; 4: 55-6.
22. Whynes DK, Baines DL, Tolley KH. Explaining variations in general practice prescribing costs per ASTRO-PU (age, sex and temporary resident originated prescribing unit). Br Med J 1996; 312: 488-9.
23. StewartBrown S, Surender R, Bradlow J, Coulter A, Doll H. The effects of fundholding in general practice on prescribing habits 3 years after introduction of the scheme. Br Med J 1995; 311: 1543-7.
24. Wilson RPH, Buchan I, Walley T. Alterations in prescribing by general practitioner fundholders - an observational study. Br Med J 1995; 511: 1347-50.
25. Trimble I, Black D. Prescribing by general practice fundholders. Br Med J 1996; 312: 848-9.
26. Berings D, Blondell L, Habraken H. The effect of industry independent drug information on the prescribing of benzodiazepines in general practice. Eur J Clin Pharm 1994; 46: 501-5.
27. Rokstad K, Straand J, Fugelli P. Can drug treatment be improved by feedback on prescribing profiles combined with therapeutic recommendations - a prospective, controlled trial in general practice. J Clin Epidemiol 1995; 48: 1061-8.
28. Russell IT, Addingtonhall JM, Avery JP et al. Medical audit in general practice. Effects on doctors clinical behaviour for common childhood conditions. Br Med J 1992; 304: 1480-4.
29. Smalley WE, Griffin MR, Fought RL, Sullivan L, Ray WA. Effect of a prior authorization requirement on the use of non steroidal anti inflammatory drugs by Medicaid patients. New Engl J Med 1995; 332: 1612-17.
30. Hawkey GM, Pearson GM, Everitt SE et al. Pitfalls in auditing upper gastrointestinal bleeding. Gut 1995; 36: T136.